Company news
Medrx Co., Ltd. news in 2024
Medrx Co., Ltd.'s news releases, calls and decks from 2024, newest first.
Summary of Business Results for the Third Quarter Ended September 30, 2024 (Consolidated)
November 8, 2024
Start of MRX-7MLL Phase I a Clinical Trial
October 28, 2024
H1 FY2024 Business Highlight & Financial Results
August 21, 2024
Summary of Business Results for the Second Quarter Ended June 30, 2024 (Consolidated)
August 9, 2024
Receipt of Complete Response Letter for MRX-5LBT
July 11, 2024
Notice of revised forecasts of consolidated financial results
April 23, 2024